Europe has approved the use of monoclonal antibody bevacizumab for the treatment of neovascular age-related macular degeneration. Medscape Medical News
Author: Medscape
Vision Impairment Tied to Isolation, Depression
Impaired vision also was linked to symptoms of anxiety in a study of older adults in the United States. Medscape Medical News
Patients With Sjögren Syndrome Fall Into Distinct Subgroups
Those with high systemic disease activity but low symptom burden fared worse over time. Medscape Medical News
Long-Release Implant Available for Diabetic Macular Oedema
The implant requires less frequent replacement than the dexamethasone alternative. Medscape News UK
A Better Way to Assess Glaucoma?
Clustering of multiple diagnostic tests in a 6-month period showed high accuracy in identifying rapid progression of glaucoma earlier than annual testing and before significant vision loss can occur. Medscape Medical News
The Best Choice for Trabeculotomy?
A 360-degree incision of the trabecular meshwork to treat glaucoma had a lower rate of second operations than the 180-degree approach, with comparable IOP outcomes, a study found. Medscape Medical News
US FDA Approves Eyenovia’s Eye Drug, Formosa Pharma Says
The U.S. Food and Drug Administration had approved Eyenovia’s eye drops to reduce inflammation and pain in patients who have undergone eye surgery, Taiwan-based Formosa… Reuters Health Information
Generic SpA Screening Tool Needed Across Comorbid Diseases
A comparison of screening tools for SpA in conditions that commonly co-occur with the disease revealed few screening tool options for patients with uveitis or IBD, compared with psoriasis. Medscape Medical News
AI Chatbots vs Ophthalmology Specialists
A large language model demonstrated proficiency in ophthalmology, matching or outperforming specialists in the management of glaucoma and retina cases. Medscape Medical News
CA Suit Targets Anti-Bias Training in Health Care
The litigation is part of a national crusade by right-leaning advocacy and legal groups against diversity, equity, and inclusion, or DEI, initiatives in health care. KFF Health News
CA Suit Targets Anti-Bias Training in Healthcare
The litigation is part of a national crusade by right-leaning advocacy and legal groups against diversity, equity, and inclusion, or DEI, initiatives in health care. KFF Health News
Will 2024 Be Easier on the Eyes?
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and office visits for retinal disease are on the horizon. Medscape Medical News
FDA OKs 10th Humira Biosimilar, Interchangeability Included
It is the tenth adalimumab biosimilar approved by the regulatory agency. Medscape Medical News
For Retina Specialists, 2024 Is a Time to Try New Tools
This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond. Medscape Medical News
Periocular Melanoma Still Rare, But May Be Increasing
Pain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants. MDedge News
2024 Will See Major Advances in Glaucoma Care
Three new treatments for dry eye disease and a new procedure and remote monitoring platform for glaucoma are due to debut in 2024, with more in the pipeline. Medscape Medical News
Harvard Docs Train Ukrainian Counterparts 2 Years Into War
Boston program aimed to mentor specialists whose medical education was forged in the remnants of the old Soviet system. Medscape Medical News
US Board Discloses Cheating, Grads Say Problem Is Rampant
USMLE says it is invalidating some scores amid mounting allegations that online sellers of test questions have been operating without consequence. Medscape Medical News
Europe Approves Neutropenia and Schizophrenia Treatments
Recommendations were also endorsed to institute measures to reduce risks from cold and flu medicines containing pseudoephedrine. Medscape Medical News
Metformin Shows Potential to Prevent Neovascular AMD
A case-control study of 174,000 individuals found that use of metformin was associated with a reduced odds of developing wet, age-related macular degeneration. Medscape Medical News